A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate

Author： Clercq Erik De  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.17, 2009-12, pp. : 2935-2937

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emtricitabine/Tenofovir Disoproxil Fumarate: In Combination with a Protease Inhibitor in HIV-1 Infection

By Perry Caroline M.  

Drugs, Vol. 69, Iss. 7, 2009-05 ,pp. : 843-857

Adis International

Access to resources Recommend Favorite

Raltegravir: In Treatment-Naive Patients with HIV-1 Infection

By Croxtall Jamie D.   Scott Lesley J.  

Drugs, Vol. 70, Iss. 5, 2010-03 ,pp. : 631-642

Adis International

Access to resources Recommend Favorite

Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients

By Gazzard Brian G  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 793-802

Informa Healthcare

Access to resources Recommend Favorite

Raltegravir to the rescue for treatment-naive patients with HIV-1

By  

Inpharma, Vol. 1, Iss. 1652, 2008-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen: A Guide to Its Use in HIV-1 Infection

By Lyseng-Williamson Katherine A.   Scott Lesley J.  

Clinical Drug Investigation, Vol. 32, Iss. 10, 2012-10 ,pp. : 715-722

Adis International

Access to resources Recommend Favorite